228 related articles for article (PubMed ID: 9853357)
1. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
[TBL] [Abstract][Full Text] [Related]
2. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
3. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
4. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
[TBL] [Abstract][Full Text] [Related]
7. 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV.
Boiani M; Cerecetto H; González M; Risso M; Olea-Azar C; Piro OE; Castellano EE; López de Ceráin A; Ezpeleta O; Monge-Vega A
Eur J Med Chem; 2001 Oct; 36(10):771-82. PubMed ID: 11738485
[TBL] [Abstract][Full Text] [Related]
8. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
Cerecetto H; González M; Risso M; Seoane G; López de Ceráin A; Ezpeleta O; Monge A; Suescun L; Mombrú A; Bruno AM
Arch Pharm (Weinheim); 2000 Nov; 333(11):387-93. PubMed ID: 11129981
[TBL] [Abstract][Full Text] [Related]
10. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic evaluation of combretafurazans.
Tron GC; Pagliai F; Del Grosso E; Genazzani AA; Sorba G
J Med Chem; 2005 May; 48(9):3260-8. PubMed ID: 15857132
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
[TBL] [Abstract][Full Text] [Related]
14. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
Bondock S; Adel S; Etman HA; Badria FA
Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
17. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
[TBL] [Abstract][Full Text] [Related]
18. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
19. Part II: Design, synthesis and antitumor action of C3/C3 bisfluoroquinolones linked-cross 2, 5-[1, 3, 4]oxadiazole.
Hu GQ; Yang Y; Yi L; Wang X; Zhang ZQ; Xie SQ; Huang WL
Yao Xue Xue Bao; 2010 Aug; 45(8):1012-6. PubMed ID: 21348428
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
